Back to Search

Identification of AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration

  • Protocol Number: 201911201
  • Principal Investigator: Jacoby, Meagan
  • Cancer Types: Leukemia, Myeloma, and Hematologic

Learn more about this study at: clinicaltrials.gov

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

In this study, the investigators will explore the feasibility of ex vivo drug screening to predict sensitivity to chemotherapy resistance and to identify novel synergy between chemotherapies.

Protocol Interventions

Peripheral blood draw, Bone marrow aspirate, Buccal swab